Interleukin-1 inhibitors are a class of medications designed to block the action of interleukin-1 (IL-1), a protein that plays a key role in inflammation and immune responses. By inhibiting IL-1, these drugs help reduce inflammation and alleviate symptoms in various autoimmune and inflammatory diseases, such as rheumatoid arthritis and gout. These inhibitors can be administered through injections and are often used when other treatments are ineffective. Examples of interleukin-1 inhibitors include anakinra and canakinumab. Their use has shown promise in improving the quality of life for patients suffering from chronic inflammatory conditions.